ChREBP regulates fructose-induced glucose production independently of insulin signaling
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Obese, insulin-resistant states are characterized by a paradoxical pathogenic condition in which the liver appears to be selectively insulin resistant. Specifically, insulin fails to suppress glucose production, yet successfully stimulates de novo lipogenesis. The mechanisms underlying this dysregulation remain controversial. Here, we hypothesized that carbohydrate-responsive element-binding protein (ChREBP), a transcriptional activator of glycolytic and lipogenic genes, plays a central role in this paradox. Administration of fructose increased hepatic hexose-phosphate levels, activated ChREBP, and caused glucose intolerance, hyperinsulinemia, hypertriglyceridemia, and hepatic steatosis in mice. Activation of ChREBP was required for the increased expression of glycolytic and lipogenic genes as well as glucose-6-phosphatase (G6pc) that was associated with the effects of fructose administration. We found that fructose-induced G6PC activity is a major determinant of hepatic glucose production and reduces hepatic glucose-6-phosphate levels to complete a homeostatic loop. Moreover, fructose activated ChREBP and induced G6pc in the absence of Foxo1a, indicating that carbohydrate-induced activation of ChREBP and G6PC dominates over the suppressive effects of insulin to enhance glucose production. This ChREBP/G6PC signaling axis is conserved in humans. Together, these findings support a carbohydrate-mediated, ChREBP-driven mechanism that contributes to hepatic insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“This is in line with the results from some studies in that hepatic esterification of FAs into TG, unlike DNL, depends on substrate delivery rather than insulin action [84-86].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [86]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ChREBPβ is transcriptionally induced by ChREBPα and amplifies the glucose response in the liver and adipose tissue [78,86].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [86]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Supporting this perspective, monosaccharides have been shown to activate ChREBP and other key lipogenic transcription factors—including SREBP1c, LXR, and PPARγ—via insulin-independent mechanisms [34,70,83,86,99].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [86]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the Western diet not only contains large amounts of AGEs, due to high levels of food processing, but is also high in fat and sugar, particularly fructose, which increases AGE production in the body, in part, by increasing circulating glucose levels via enhanced hepatic glucose production and insulin resistance.[4]”
From The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction (2021) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In response to the intake of large carbohydrates, fructose could enhance hepatic lipogenic capacity by inducing hepatic master transcription factors.93 94 95”
From Dietary sugar consumption and health: umbrella review (2023) · cites this paper as [94]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism
Taniguchi, C. M., Ueki, K., & Kahn, C. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23187 · Cited by 272
RetractedA SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · cited 1×
“These studies do not address the observation that hyperinsulinemia fails to suppress hepatic glucose-6-phosphatase ( G6PC ) expression in insulin-resistant humans (12), a condition where increased DNL in association with steatosis and hypertriglyceridemia is readily apparent (13, 14).”
BackgroundSugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes
Malik, V. S., Popkin, B. M., Bray, G. A., Després, J.-P., Willett, W. C., & Hu, F. B. (2010) · Diabetes Care · doi:10.2337/dc10-1079 · Cited by 2,116
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322 · cited 1×
“However, others reported that defects in hepatic insulin signaling occur at the level of the insulin receptor, proximal to the proposed branch points in insulin signaling, thereby precluding differential insulin signaling as a mechanism to explain this paradox (7).”
Background
Cited by
Items 101–200 of 212
Inter-organ metabolic interaction networks in non-alcoholic fatty liver disease
Fan, Y., Zhang, S., Wang, Y., Wang, H., Li, H., & Bai, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1494560 · Cited by 28
“High fructose intake also accelerates the provision of cytoplasmic acetyl-CoA for DNL via acetyl-CoA synthetase 2 (ACSS2) (16).”
InfluentialMao, T., Sun, Y., Xu, X., & He, K. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000234 · Cited by 27
Nikolaou, K. C., Godbersen, S., Manoharan, M., Wieland, S. F., Heim, M. H., & Stoffel, M. (2023) · JCI Insight · doi:10.1172/jci.insight.164694 · Cited by 25
Chen, Y., Lin, H., Qin, L., Lu, Y., Zhao, L., Xia, M., Jiang, J., Li, X., Yu, C., Zong, G., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2494 · Cited by 23
Shimada, M., Ichigo, Y., Shirouchi, B., Takashima, S., Inagaki, M., Nakagawa, T., & Hayakawa, T. (2019) · Nutrition Research · doi:10.1016/j.nutres.2019.01.002 · Cited by 24
Crosstalk between TM4SF5 and GLUT8 regulates fructose metabolism in hepatic steatosis
Lee, H., Kim, E., Shin, E.-A., Shon, J. C., Sun, H., Kim, J. E., Jung, J. W., Lee, H., Pinanga, Y., Song, D.-G., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101451 · Cited by 24
“After 90 min (fructose transit time from the mouth to the liver [25]), the animals were sacrificed and their blood and liver tissues were analyzed.”
MethodSelf-citationKakazu, E., Mino, M., & Kanto, T. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2025.0048 · Cited by 28
Diet-induced loss of adipose hexokinase 2 correlates with hyperglycemia
Shimobayashi, M., Thomas, A., Shetty, S., Frei, I. C., Wölnerhanssen, B. K., Weißenberger, D., Vandekeere, A., Planque, M., Dietz, N., Ritz, D., et al. (2023) · eLife · doi:10.7554/elife.85103 · Cited by 24
Sugar causes obesity and metabolic syndrome in mice independently of sweet taste
Andrés-Hernando, A., Kuwabara, M., Orlicky, D. J., Vandenbeuch, A., Cicerchi, C., Kinnamon, S. C., Finger, T. E., Johnson, R. J., & Lanaspa, M. A. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00529.2019 · Cited by 22
“ChREBP is a carbohydrate-dependent transcription factor stimulated by both glucose and fructose whose activation drives sugar-dependent lipogenesis (14, 22, 23).”
BackgroundThe effects of fructose and metabolic inhibition on hepatocellular carcinoma
Dewdney, B., Alanazy, M., Gillman, R., Walker, S. L., Wankell, M., Qiao, L., George, J., Roberts, A. A., & Hebbard, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-73653-5 · Cited by 23
Fan, Q., Nørgaard, R. C., Bindesbøll, C., Lucas, C., Dalen, K. T., Babaie, E., Itkonen, H. M., Matthews, J. B., Nebb, H. I., & Grønning-Wang, L. M. (2017) · Nutrients · doi:10.3390/nu9070678 · Cited by 21
“Interestingly, a recent study showed that ChREBP induces hepatic G6pc expression and glucose production by short-term fructose feeding in mice [25], suggesting a role for ChREBP in contributing to selective hepatic insulin resistance.”
BackgroundÖzkan, H., & Yakan, A. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2019.03.013 · Cited by 21
Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in citrin deficiency
Tiwari, V., Jin, B., Sun, O., Gonzalez, E. D. J. L., Chen, M.-H., Wu, X., Shah, H., Zhang, A., Herman, M. A., Spracklen, C. N., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01399-3 · Cited by 25
“Fructose would thus be more lipogenic than glucose because it results in greater ChREBP activation 59 because fructolysis (Fig.”
Self-citationLeibowitz, A., Bier, A., Gilboa, M., Peleg, E., Barshack, I., & Grossman, E. (2018) · Nutrients · doi:10.3390/nu10030341 · Cited by 23
“They demonstrated that ChREBP β regulated carbohydrate metabolism in a fructose-fed rat model [29].”
BackgroundMukherjee, S. K., Chakraborty, M., Ulmasov, B., McCommis, K. S., Zhang, J., Carpenter, D. H., Msengi, E. N., Haubner, J., Guo, C. H., Pike, D. P., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101364 · Cited by 20
“25% cholesterol and HFrD: 60% kcal fructose) to induce the full spectrum of NAFLD/NASH [21e23] and hepatic metabolic dysfunction in mice [24], we aimed to determine the impact of hepatocyte-specific and whole-body deletion of Ip6k1 on hepatic metabolism and NAFLD/NASH.”
BackgroundDungubat, E., Fujikura, K., Kuroda, M., Toshio, F., & Takahashi, Y. (2025) · Nutrients · doi:10.3390/nu17132211 · Cited by 25
Wang, L., Wang, H., Wu, J., Ji, C., Wang, Y., Gu, M., Li, M., & Yang, H. W. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1635638 · Cited by 31
Soto, L. G. D. L. P., Gutierrez-Uribe, J. A., Sharma, A. K., & Ramírez‐Jiménez, A. K. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.09.035 · Cited by 20
Fructose overconsumption impairs hepatic manganese homeostasis and ammonia disposal
Shi, J., Chen, Y.-X., Feng, Y., Yang, X., Lin, J., Wang, T., Wei, C., Ma, X., Yang, R., Cao, D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43609-0 · Cited by 19
“The expression and activity of ChREBP are induced by carbohydrates, especially fructose, which is relevant in the pathogenesis of metabolic diseases caused by excessive fructose consumption 38,39 .”
Targeting acetyl-CoA carboxylases for the treatment of MASLD
Mateo-Marín, M. A., & Alves‐Bezerra, M. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100676 · Cited by 28
Causative and Sanative dynamicity of ChREBP in Hepato-Metabolic disorders
Daniel, P. V., & Mondal, P. (2020) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2020.151128 · Cited by 27
An, J., Astapova, I. I., Zhang, G., Cangelosi, A. L., Ilkayeva, O., Marchuk, H., Muehlbauer, M. J., George, T., Brozinick, J. T., Herman, M. A., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115278 · Cited by 19
Self-citationAmeliorative Effect of Myricetin on Nonalcoholic Fatty Liver Disease in ob/ob Mice
Choi, H., Shin, J.-Y., & Kim, J.-I. (2021) · Journal of Medicinal Food · doi:10.1089/jmf.2021.k.0090 · Cited by 19
“29 ChREBP also directly activates the SREBP-1c gene.”
Self-citationLiu, X., Jiang, Y., Ye, J., & Wang, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.999412 · Cited by 21
Rabbani, N., & Thornalley, P. J. (2025) · Clinical Science · doi:10.1042/cs20257727 · Cited by 17
“These pathways may be operating clinically as liver biopsies from patients with MASLD showed positive correlation of ChREBPβ with FASN, L-PK, PCK1, and G6PC [82].”
InfluentialHuang, W., Hua, Y., Wang, F., Xu, J., Yuan, L., Zhao, J., Wang, W., & Zhao, Y. (2022) · Fish Physiology and Biochemistry · doi:10.1007/s10695-022-01160-7 · Cited by 15
“The high-fructose diets could activate hepatic carbohydrate-responsive element-binding proteins (Kim et al. 2016), which upregulated the branched-chain keto acid dehydrogenase kinase (BDK) and downregulated the protein phosphatase m1K (PPM1K).”
Hu, Y., Semova, I., Sun, X., Kang, H. M., Chahar, S., Hollenberg, A. N., Masson, D., Hirschey, M. D., Miao, J., & Biddinger, S. B. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.782557 · Cited by 19
“In Flox controls, fructose increased expression of Srebp-1c, Chrebp, and the more active transcript of CHREBP, Chrepb(9, 30).”
BackgroundSelf-citationXiong, Y., Xu, Z., Wang, Y., Kuang, S., & Shan, T. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m081463 · Cited by 16
“perinsulinemia and reduced glucose uptake into adipocytes, which could promote hepatic glucose and lipid production and drive hepatic insulin resistance (22, 28, 41).”
BackgroundXu, Z., Sha, W., Hou, C., Amakye, W. K., Yao, M., & Ren, J. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.09.043 · Cited by 15
Age-dependent hepatic alterations induced by a high-fat high-fructose diet
Casagrande, B. P., Gomes, M. F. P., Moura, E. O. C., Santos, A., Kubota, M. C., Ribeiro, D. A., Pisani, L. P., Medeiros, A., & Estadella, D. (2019) · Inflammation Research · doi:10.1007/s00011-019-01223-1 · Cited by 18
Youn, D. Y., Xiaoli, A. M., Zong, H., Okada, J., Liu, L. P., Pessin, J. B., Pessin, J. E., & Yang, F. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101227 · Cited by 17
“The G6pc gene also contains a ChREBP-responsive cis-DNA element and fructose is a potent activator of ChREBP, which has been reported to be the basis for the elevated activation of G6pc expression by fructose [7].”
BackgroundInfluentialBier, A., Shapira, E., Khasbab, R., Sharabi, Y., Grossman, E., & Leibowitz, A. (2022) · Biology · doi:10.3390/biology11040618 · Cited by 22
“It was also demonstrated in this study that ChREBPβ is responsible for fructose-induced “fatty liver” and liver insulin resistance [22].”
BackgroundMonar, G. V. F., Cruz, C. S., & Martinez, E. C. (2025) · Journal of Nutrition and Metabolism · doi:10.1155/jnme/5571686 · Cited by 17
“It induces gene expression as a response to consumption of carbohydrates [54–60] in an insulin-independent process [61].”
Liu, Y., Fan, Y., Liu, J., Liu, X., Li, X., & Hu, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1499602 · Cited by 24
Unfolded Protein Response: Cause or Consequence of Lipid and Lipoprotein Metabolism Disturbances?
Pinto, B., França, L. M., Laurindo, F. R. M., & Paes, A. M. D. A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-11488-6_5 · Cited by 15
Ford, B. E., Chachra, S. S., Alshawi, A., Brennan, A., Harnor, S. J., Cano, C., Baker, D. J., Smith, D. M., Fairclough, R. J., & Agius, L. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14111 · Cited by 14
“ChREBP (encoded by Mlxipl) is a major transcriptional regulator in liver that is activated by high dietary carbohydrate and is frequently described as a "glucose sensor" because it is activated by high glucose.(38) However, the stimulus for its activation is the raised phosphate esters and not glucose itself, as shown…”
BackgroundInfluentialVarga, V., Murányi, Z., Kurucz, A., Marcolongo, P., Benedetti, A., Bánhegyi, G., & Margittai, É. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205039 · Cited by 16
“As a recent confirmation, it has been shown that a high-fructose diet markedly induces intestinal ChREBP-β expression [29,30].”
BackgroundThe glucose-sensing transcription factor ChREBP is targeted by proline hydroxylation
Heidenreich, S., Weber, P., Stephanowitz, H., Petricek, K. M., Schütte, T., Oster, M., Salo, A. M., Knauer, M., Göhring, I., Yang, N. Y., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014402 · Cited by 17
“Pck1, G6pc, and Fasn are also direct targets of ChREBP (3, 12, 48, 49), suggesting that ChREBP may be involved in the observed regulations.”
BackgroundInsulin‐Mediated PI3K and AKT Signaling
Kwon, H., & Pessin, J. E. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch39 · Cited by 17
Fernández, A., Mazuecos, L., Pintado, C., Rubio, B., López, V., Solís, A. J. D., Rodríguez-Pérez, M., Andrés, A., & Gallardo, N. (2019) · Nutrients · doi:10.3390/nu11081865 · Cited by 17
“Accordingly, these carbohydrate metabolites or the newly synthesized glucose could activate ChREBP and the lipogenic genes that redirect carbons from glucose to glycolysis and lipogenesis, linking endogenous glucose production with lipogenesis, in line with data obtained from high fructose feeding mice and in liver-sp…”
BackgroundInfluentialSuzuki, S., Yokoyama, A., Noro, E., Aoki, S., Shimizu, K., Shimada, H., & Sugawara, A. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0133 · Cited by 14
“ChREBP has also been suggested to be involved in the etiology and its complications of diabetes mellitus [7, 8].”
BackgroundTargeting hepatocyte carbohydrate transport to mimic fasting and calorie restriction
Kading, J. C., Finck, B. N., & DeBosch, B. J. (2020) · FEBS Journal · doi:10.1111/febs.15482 · Cited by 13
Jois, T., & Sleeman, M. W. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12473 · Cited by 16
Bentanachs, R., Blanco, L., Montesinos, M., Sala‐Vila, A., Lázaro, I., Rodríguez-Morató, J., Sánchez, R. M., Laguna, J. C., Roglans, N., & Alegret, M. (2023) · Nutrients · doi:10.3390/nu15183909 · Cited by 14
“Fibroblast growth factor 21 (FGF21) is a hepatokine that regulates adipose tissue lipolysis; it has been reported that fructose-rich diets increase the circulating levels of FGF21 in rodents [15].”
BackgroundChen, Y.-W., Ahn, I. S., Wang, S. S.-M., Majid, S., Diamante, G., Cely, I., Zhang, G., Cabanayan, A., Komzyuk, S., Bonnett, J., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115690 · Cited by 17
Chen, Y., Wang, Y., Zhao, Y., & Wang, J. (2018) · Bioscience Reports · doi:10.1042/bsr20180767 · Cited by 11
Self-citationRetractedDietary Manipulations for Nonalcoholic Fatty Liver Disease (NAFLD)
Cheah, M. C. C., McCullough, A. J., & Goh, G. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813822-9.00005-9 · Cited by 18
Murao, N., Seino, Y., Morikawa, R., Hidaka, S., Haraguchi, T., Tomatsu, E., Habara, M., Ohno, T., Yokoi, N., Harada, N., et al. (2025) · The Journal of Physiology · doi:10.1113/jp289067 · Cited by 12
“Mechanistically, fructose stimulates hepatic glucose production by upregulating glucose-6-phosphatase (G6PC) via carbohydrate response element-binding protein (ChREBP), partly over-riding insulin action (Kim et al., 2019).”
Fructose: metabolic signal and modern hazard
Johnson, R. J., Lanaspa, M. A., Tolan, D. R., Goncalves, M. D., Softic, S., Stanhope, K. L., Sánchez‐Lozada, L. G., Herman, M. A., & Rabinowitz, J. D. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01506-y · Cited by 14
Self-citationSarkar, S., Ghosh, S., & Biswas, M. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.102062 · Cited by 12
“This gene expression targets FAS and ACC expression, which increases the TG pool [93], [94].”
Bier, A., Khasbab, R., Haberman, Y., Braun, T., Hadar, R., Sosnovski, K. E., Amir, A., Leibowitz, A., & Grossman, E. (2020) · Nutrients · doi:10.3390/nu12010203 · Cited by 12
“HFrD enhanced the expression of Chrebpβ, Fasn and Elovl6 which are key regulator genes in the lipogenesis process, and this enhancement was also seen in HFrD antibiotics treated rats.”
BackgroundInfluentialThe induced-fit and catalytic mechanisms of human G6PC1
Chen, Q., Wang, Y., Li, R., Bai, Q., & Zhao, Y. (2025) · Cell Discovery · doi:10.1038/s41421-025-00814-z · Cited by 13
“Furthermore, elevated fructose levels are linked to the upregulation of G6PC1 activity 26 .”
High-fat-diet-induced hepatic insulin resistance per se attenuates murine de novo lipogenesis
Goedeke, L., Strober, J. W., Suh, R., Paolella, L. M., Li, X., Rogers, J. C., Petersen, M. C., Nasiri, A. R., Casals, G., Kahn, M., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111175 · Cited by 15
“In addition to the effect of reduced but present insulin signaling on lipogenic protein abundance, the increase in ChREBP and L-PK observed in whole-body insulin-resistant refed mice suggests that the lipogenic transcription factor ChREBP 31,32 may play a role as well.”
New insights into the inter-organ crosstalk mediated by ChREBP
Carbinatti, T., Régnier, M., Parlati, L., Benhamed, F., & Postic, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1095440 · Cited by 14
“Worth mentioning is that high fructose consumption strongly stimulates ChREBPb, rather than ChREBPa, which is accompanied by increased expression of glycolytic and lipogenic genes in the liver of mice (106).”
BackgroundChREBPβ is dispensable for the control of glucose homeostasis and energy balance
Recazens, E., Tavernier, G., Dufau, J., Bergoglio, C., Benhamed, F., Cassant‐Sourdy, S., Marqués, M.-A., Caspar‐Bauguil, S., Brion, A., Monbrun, L., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.153431 · Cited by 13
“After other nutritional challenges, such as high fructose or alcohol intake, it may be envisaged that ChREBPβ contributes more to ChREBP transcriptional activity than in the conditions reported here (13, 31, 32).”
Wang, P., Xiao, H., Wu, T., Fu, Q., Song, X., Zhao, Y., Li, Y., Huang, J., & Song, Z. (2024) · Animal nutrition · doi:10.1016/j.aninu.2024.04.006 · Cited by 12
Circulating glycerate predicts resilience to fructose-induced hepatic steatosis
Ramirez, C. B., Ahn, I. S., Rubtsova, V. I., Cely, I., Le, J., Kim, J., Jung, S., Kelly, M. E., Kim, Y., Bae, H., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.03.017 · Cited by 12
Self-citationGong, K., Zhang, Z., Chen, S., Zhu, X., Wang, M.-Y., Yang, X., Ding, C., Han, J., Li, Q., & Duan, Y. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01121-7 · Cited by 9
“Carbohydrate-responsive element binding protein (ChREBP) is hyperactivated by a high fructose load compared to glucose to promote hepatic de novo lipogenesis (DNL) more potently and induce metabolic diseases [6].”
BackgroundHippo pathway cooperates with ChREBP to regulate hepatic glucose utilization
Shu, Z., Yi, G., Deng, S., Huang, K., & Wang, Y. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.06.105 · Cited by 10
Zhang, D., Wang, S., Ospina, E., Shabandri, O., Lank, D. S., Akakpo, J. Y., Zhao, Z., Yang, M., Wu, J., Jaeschke, H., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1683 · Cited by 9
Glycerol's contribution to lactate production outside of a glucose intermediate in fasting humans
Shah, A. M., Wang, Y., Su, X., & Wondisford, F. E. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155214 · Cited by 9
Dang, D. X., Zhou, H., Lou, Y., & Li, D. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.944063 · Cited by 8
“It plays a key role in the terminal step of gluconeogenesis and glycogenolysis, and it can catalyze the conversion of glucose-6-phosphate to glucose, thus releasing glucose from the cell (41, 42).”
BackgroundFructose, a trigger of metabolic diseases?—a narrative review
Baumann, A., Brandt, A., & Bergheim, I. (2022) · Exploration of Digestive Diseases · doi:10.37349/edd.2022.00005 · Cited by 10
“[92] further suggest that through carbohydrate responsive element-binding protein-dependent mechanisms, glucose-6-phosphatase is induced in livers of fructose-fed animals, which in turn may add to an enhanced glucose production.”
BackgroundShokri, B., Mohebbi, H., & Mehrabani, J. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02347-y · Cited by 7
“It directly activates sterol regulatory-element binding protein 1c (SREBP1c), a key transcriptional regulator of DNL [11], and enhances the upregulation of carbohydrate-respon-sive element-binding protein (ChREBP), which governs the expression of lipogenic genes [12].”
BackgroundCohen, C. C., Dabelea, D., Michelotti, G. A., Tang, L., Shankar, K., Goran, M. I., & Perng, W. (2022) · Metabolites · doi:10.3390/metabo12060559 · Cited by 11
“This effect may be due to unregulated hepatic fructose metabolism [22], which can lead to hepatic substrate overload and increased hepatic de novo lipogenesis [23,24].”
BackgroundLee, M., Park, S., Xu, Y., Kim, J.-E., Han, H., Lee, J.-H., Paik, J. K., & Lee, H. (2022) · Applied Sciences · doi:10.3390/app12136745 · Cited by 8
Self-citationCioffi, C. E., Welsh, J. A., Alvarez, J. A., Hartman, T. J., Narayan, K. M. V., & Vos, M. B. (2019) · Current Developments in Nutrition · doi:10.1093/cdn/nzz130 · Cited by 6
“152 PIR 130–300% 422 (45) 384 (35) 534 (37) 447 (38) 274 (37) 345 (39) 0.”
BackgroundPosicionamento Brasileiro sobre Síndrome da Quilomicronemia Familiar – 2023
Izar, M. C. D. O., Santos, R. D., Assad, M. H. V., Chagas, A. C. P., Toledo, A. D. O., Nogueira, A. C. C., Souto, A. C. C. F., Lottenberg, A. M., Chacra, A. P. M., Ferreira, C. E. D. S., et al. (2023) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20230203 · Cited by 10
ChREBP mediates metabolic remodeling in FBP1-deficient liver
Wang, C.-M., Bai, Q.-F., Liu, Y., Lin, J., Wei, C., Ma, X., Zhao, J.-M., Zhu, M., Chen, Y.-X., Shi, Y., et al. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00875.2024 · Cited by 5
Pereira, G. A., Sodré, F. S., Murata, G. M., Amaral, A. G., Payolla, T. B., Campos, C. V., Sato, F. T., Anhê, G. F., & Bordin, S. A. (2020) · Nutrients · doi:10.3390/nu12103062 · Cited by 6
The Role of Carbohydrate Response Element–Binding Protein in the Development of Liver Diseases
Iizuka, K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814466-4.00022-7 · Cited by 7
Hong, J. G., Carbajal, Y., Trotman, J. C., Glass, M., Sclar, V., Alter, I. L., Zhang, P., Wang, L., Chen, L., Petitjean, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.17.576067 · Cited by 4
Krishnamurthy, K. A., Rutten, M. G. S., Hoogerland, J. A., van Dijk, T. H., Bos, T., Koehorst, M., de Vries, M. P., Kloosterhuis, N., Havinga, H., Schomakers, B. V., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101838 · Cited by 4
“Interestingly, we also observed that mRNA levels of Gck , rather than Gckr [4,40], were affected by shChREBP treatment.”
BackgroundIsotype-selective roles of hepatic acetyl-CoA carboxylases in a mouse model of fatty liver disease
Beretta, M., Vancuylenburg, C. S., Shrestha, R., Olzomer, E. M., Osborne, B., Zhou, M., Zhang, S., Hargreaves, A., Byrne, F. L., & Hoehn, K. L. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102264 · Cited by 6
“Impor-tantly, it has been reported that fructose intake promotes liver metabolic dysregulations more effectively than glucose via upregulation of lipogenic enzymes [44,45], even in healthy individuals [46].”
Liquid fructose and liver insulin signaling: Molecular mechanisms controlling hepatic steatosis
Sangüesa, G., Roglans, N., Laguna, J. C., & Alegret, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-849886-6.00004-5 · Cited by 3
Alireza, H. (2021) · International Journal of Membrane Science and Technology · doi:10.15379/2410-1869.2021.08.02.04 · Cited by 3
Behrens, J., Fuh, M. M., Haas, D. T., Jaeckstein, M. Y., Heine, M., Siebels, B., Worthmann, A., Krahmer, N., Heeren, J., & Scheja, L. (2025) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025229 · Cited by 2
“In parallel to metabolically supplying the DNL pathway, fructose metabolism in hepatocytes efficiently stimulates the transcription of DNL enzyme genes, predominantly through activation of the transcription factor carbohydrate response element - binding protein (ChREBP) [9,13].”
Genetic risk of steatotic liver disease: Pathogenesis, prognosis, and implications for treatment
Kozlitina, J., Romeo, S., & Hobbs, H. H. (2026) · Hepatology · doi:10.1097/hep.0000000000001758 · Cited by 2
Czynnik transkrypcyjny ChREBP â koordynator metabolizmu węglowodanów i lipidów
Krawczak, J., Owczarek, A., & Winiarska, K. (2020) · Postępy Biochemii · doi:10.18388/pb.2019_282 · Cited by 3
del Castillo, C. E. C., Deniz, O., van Geest, F., Rosseels, L., Stockmans, I., Robciuc, M. R., Carpentier, S., Wölnerhanssen, B. K., Meyer‐Gerspach, A. C., Peterli, R., et al. (2025) · Science Advances · doi:10.1126/sciadv.adt4548 · Cited by 3
“Previous studies suggested that the glucose metabolite glucose- 6-phosphate (G6P) promotes ChREBP transcriptional activity ( 4 – 6 ), although the underlying molecular mechanism is still unclear.”
A Short-Term Sucrose Diet Impacts Cell Proliferation of Neural Precursors in the Adult Hypothalamus
Recabal, A., López, S., Salgado, M., Palma, A., Obregón, A. M., Elizondo-Vega, R. J., Sáez, J. C., & García, M. D. L. Á. (2022) · Nutrients · doi:10.3390/nu14132564 · Cited by 2
Ting, K. K. Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1407108 · Cited by 2
Gao, M., Lin, C., Lǐ, Y., Li, L., Chen, X., Wang, J., Du, W., & Pan, Q. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01945-9 · Cited by 2
“Similarly, SREBP-1c is stimulated by insulin and glucose, leading to the upregulation of lipogenic genes and contributing to hepatic lipid accumulation [28].”
Self-citationSugar Shockwaves: How the Fructose–Glucose–ChREBP Pathway Hijacks Liver Metabolism
Gugliucci, A. (2026) · Life · doi:10.3390/life16081313 · Cited by 1
“…including peroxisome proliferator-activated receptor (PPAR) alpha or gamma, estrogen-related receptors, and liver X receptor, are coactivated by peroxisome proliferator-activated receptor gamma coactivator 1b (PGC-1b), which supports multiple sugar-induced metabolic changes [28,131,141,147,148].”
New Insight Into Male Infertility: Deviation From Basic Tenets of Life
Nasr‐Esfahani, M. H., Naderi, N., Tavalaee, M., & Razi, M. (2026) · Oxidative Medicine and Cellular Longevity · doi:10.1155/omcl/4433444 · Cited by 1
Rajas, F., & Mithieux, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-849886-6.00021-5 · Cited by 2
“For example, fructose increases lipogenesis more strongly than glucose, through a significant activation of ChREBP (Kim et al., 2016).”
BackgroundHepatic Lipid Homeostasis in NAFLD
Zhang, S., Ji, B., Yang, C., & Li, Y. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.108168 · Cited by 1
Non-alcoholic Fatty Liver Disease - New Insight and Glance Into Disease Pathogenesis
Kang, S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100998 · Cited by 1
RECENT ADVANCES IN SMALL-MOLECULE INHIBITORS OF KETOHEXOKINASE (KHK)
Ebner, D. C., Tesz, G. J., & Futatsugi, K. (2023) · Medicinal chemistry reviews · doi:10.1021/mc-2023-vol58.ch06 · Cited by 3
Thankam, F. G., Radwan, M. M., & Agrawal, D. K. (2020) · Springer eBooks · doi:10.1007/978-3-030-47336-5_13 · Cited by 1
Therapeutic Approaches for Nonalcoholic Steatohepatitis ( NASH )
Glatthar, R., & Arch, R. H. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc274 · Cited by 1
Managing Metabolic Health Impact of Fructose-Containing Beverages
Djordjevic, A. D., & Veličković, N. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815260-7.00001-8 · Cited by 1
Payolla, T. B. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2019.tde-18092019-163756
Teleman, A. A., & Figlia, G. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738090259.793578803
Bridges, D. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732607607.793543134
Ha, S. M., Ahn, I., Kowal, T., Yoon, J. G., Olson, C. A., Diamante, G., Cely, I., Zhang, G., Wang, S., Garcia, K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.06.506855
Combatting the Fructose Epidemic: Fruitful or Fruitless?
Buziau, A. M. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231113ab
Hepatic Safety in Rats Fed on Fructose, Glucose, or Sucrose When Combine with A Moderate Fat Diet
Nasr, N., Elkattawy, A. M., Kahilo, K. A., Sadek, K. M., Elhady, S. A., El-Sawy, H. B., & Dorghamm, D. A. (2023) · Egyptian Journal of Veterinary Science · doi:10.21608/ejvs.2023.230165.1563
“A new study in response to this paradigm, however, reveals that fructose also activates ChREBP, namely via triggering a second promoter in the ChREBP gene and an alternative splicing event to create the ChREBP-isoform [16].”
BackgroundInfluentialJeyaraj, F. T., Vennam, S. S., Nelson, K. L., Watts, K., Goss, L. R., Nance, B., Mass, B. B., & Voruganti, V. S. (2026) · Food & Function · doi:10.1039/d5fo03248b
Metadata
- Authors
- Kim, M.-S., Krawczyk, S. A., Doridot, L., Fowler, A. J., Wang, J. X., Trauger, S. A., Noh, H.-L., Kang, H. J., Meissen, J. K., Blatnik, M., Kim, J. K., Lai, M., & Herman, M. A.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- University of Massachusetts Chan Medical School (US)
- Pfizer (United States) (US)
- Broad Institute (US)
- Corresponding author
- Herman, Mark A.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2016-09-26
- Volume
- 126
- Issue
- 11
- Pages
- 4372-4386
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5096918
- OpenAlex
- W2521958286
- Cited by
- 212
- References
- 69
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 12 · 2023: 21 · 2022: 24 · 2021: 21 · 2020: 32 · 2019: 30 · 2018: 15 · 2017: 21 · 2016: 2
- FWCI
- 23.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Funders
- National Institutes of Health (5u2cdk093000-11)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057521, U24DK093000, U2C-DK093000, R01DK100425, K23DK083439, T32DK007516)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- ChREBP, fructose, hepatic glucose production, hepatic insulin resistance, glucose-6-phosphatase, glucose-6-phosphate, FOXO1, hepatic steatosis, hypertriglyceridemia, hyperinsulinemia, impaired glucose tolerance, de novo lipogenesis, glycolytic genes, carbohydrate metabolism
- MeSH terms
- Forkhead Box Protein O1, Animals, Fatty Liver, Female, Fructose, Glucose, Glucose-6-Phosphatase, Glycolysis, Humans, Insulin, Insulin Resistance, Male, Nuclear Proteins, Transcription Factors, Signal Transduction, Glucose Intolerance, Mice, Knockout, Lipogenesis, Mice, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.